Bone Marrow Support of the Heart in Pressure Overload is Lost with Aging

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2011 Jan 5

PMID 21203577

Citations 18

Authors

Nikolai A Sopko

Benjamin A Turturice

Mitchell E Becker

Chase R Brown

Feng Dong

Zoran B Popovic

Marc S Penn

Affiliations

Soon will be listed here.

Abstract

Rationale: Exogenous stem cell delivery is under investigation to prevent and treat cardiac dysfunction. It is less studied as to the extent endogenous bone marrow derived stem cells contribute to cardiac homeostais in response to stress and the affects of aging on this stress response.

Objective: To determine the role of bone marrow (BM) derived stem cells on cardiac homeostasis in response to pressure overload (PO) and how this response is altered by aging.

Methods And Results: Young (8 weeks) and old (>40 weeks) C57/b6 mice underwent homo- and heterochronic BM transplantation prior to transverse aortic constriction (TAC). We found that older BM is associated with decreased cardiac function following TAC. This decreased function is associated with decrease in BM cell engraftment, increased myocyte apoptosis, decreased myocyte hypertrophy, increased myocardial fibrosis and decreased cardiac function. Additionally, there is a decrease in activation of resident cells within the heart in response to PO in old mice. Interestingly, these effects are not due to alterations in vascular density or inflammation in response to PO or differences in ex vivo stem cell migration between young and old mice.

Conclusions: BM derived stem cells are activated in response to cardiac PO, and the recruitment of BM derived cells are involved in cardiac myocyte hypertrophy and maintenance of function in response to PO which is lost with aging.

Citing Articles

Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population.

Meshko B, Volatier T, Mann J, Kluth M, Ganss C, Frank M Int J Mol Sci. 2024; 25(17).

PMID: 39273646 PMC: 11395824. DOI: 10.3390/ijms25179702.

Cardiac recovery from pressure overload is not altered by thyroid hormone status in old mice.

Kerp H, Gassen J, Grund S, Hones G, Dorr S, Mittag J Front Endocrinol (Lausanne). 2024; 15:1339741.

PMID: 38455657 PMC: 10917895. DOI: 10.3389/fendo.2024.1339741.

Assessment of Myocardial Diastolic Dysfunction as a Result of Myocardial Infarction and Extracellular Matrix Regulation Disorders in the Context of Mesenchymal Stem Cell Therapy.

Piatek-Matuszak P, Paslawski R, Paslawska U, Kiczak L, Plociennik M, Janiszewski A J Clin Med. 2022; 11(18).

PMID: 36143077 PMC: 9502668. DOI: 10.3390/jcm11185430.

Loss of dynamic regulation of G protein-coupled receptor kinase 2 by nitric oxide leads to cardiovascular dysfunction with aging.

Lieu M, Traynham C, de Lucia C, Pfleger J, Piedepalumbo M, Roy R Am J Physiol Heart Circ Physiol. 2020; 318(5):H1162-H1175.

PMID: 32216616 PMC: 7346533. DOI: 10.1152/ajpheart.00094.2020.

Engineering stem cell cardiac patch with microvascular features representative of native myocardium.

Qian Z, Sharma D, Jia W, Radke D, Kamp T, Zhao F Theranostics. 2019; 9(8):2143-2157.

PMID: 31149034 PMC: 6531308. DOI: 10.7150/thno.29552.

References

Dimmeler S, Zeiher A . Wanted! The best cell for cardiac regeneration. J Am Coll Cardiol. 2004; 44(2):464-6. DOI: 10.1016/j.jacc.2004.06.001. View

Li X, Ma Y, Yang Y, Liu F, Chen B, Han W . Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure. Clin Exp Pharmacol Physiol. 2009; 36(11):1054-61. DOI: 10.1111/j.1440-1681.2009.05243.x. View

Fan M, Chen W, Liu W, Du G, Jiang S, Tian W . The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res. 2010; 13(4):429-38. DOI: 10.1089/rej.2009.0986. View

Livi U, Luciani G, Thiene G, Gallucci V . [Controversies in the selection of donors in heart transplants]. G Ital Cardiol. 1992; 22(12):1405-14. View

Matsuura K, Honda A, Nagai T, Fukushima N, Iwanaga K, Tokunaga M . Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest. 2009; 119(8):2204-17. PMC: 2719947. DOI: 10.1172/JCI37456. View

Bian J, Popovic Z, Benejam C, Kiedrowski M, Rodriguez L, Penn M . Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy. Circ Res. 2007; 100(11):1626-33. DOI: 10.1161/01.RES.0000269778.75877.68. View

Yasukawa H, Hoshijima M, Gu Y, Nakamura T, Pradervand S, Hanada T . Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest. 2001; 108(10):1459-67. PMC: 209425. DOI: 10.1172/JCI13939. View

Gonzales C, Pedrazzini T . Progenitor cell therapy for heart disease. Exp Cell Res. 2009; 315(18):3077-85. DOI: 10.1016/j.yexcr.2009.09.006. View

Moens A, Takimoto E, Tocchetti C, Chakir K, Bedja D, Cormaci G . Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation. 2008; 117(20):2626-36. PMC: 2614930. DOI: 10.1161/CIRCULATIONAHA.107.737031. View

10.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

11.

Dong F, Khalil M, Kiedrowski M, OConnor C, Petrovic E, Zhou X . Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling. Circ Res. 2009; 106(3):601-10. DOI: 10.1161/CIRCRESAHA.109.208967. View

12.

Conboy I, Conboy M, Wagers A, Girma E, Weissman I, Rando T . Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005; 433(7027):760-4. DOI: 10.1038/nature03260. View

13.

Heineke J, Auger-Messier M, Xu J, Oka T, Sargent M, York A . Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest. 2007; 117(11):3198-210. PMC: 2045611. DOI: 10.1172/JCI32573. View

14.

Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R . Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005; 115(8):2108-18. PMC: 1180541. DOI: 10.1172/JCI24682. View

15.

Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A . Human cardiac stem cells. Proc Natl Acad Sci U S A. 2007; 104(35):14068-73. PMC: 1955818. DOI: 10.1073/pnas.0706760104. View

16.

Limana F, Bertolami C, Mangoni A, Di Carlo A, Avitabile D, Mocini D . Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. J Mol Cell Cardiol. 2009; 48(4):609-18. DOI: 10.1016/j.yjmcc.2009.11.008. View

17.

Peng Y, Popovic Z, Sopko N, Drinko J, Zhang Z, Thomas J . Speckle tracking echocardiography in the assessment of mouse models of cardiac dysfunction. Am J Physiol Heart Circ Physiol. 2009; 297(2):H811-20. DOI: 10.1152/ajpheart.00385.2009. View

18.

Muller P, Kazakov A, Semenov A, Bohm M, Laufs U . Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells. Cardiovasc Res. 2007; 77(1):151-9. DOI: 10.1093/cvr/cvm037. View

19.

Urbanek K, Quaini F, Tasca G, Torella D, Castaldo C, Nadal-Ginard B . Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A. 2003; 100(18):10440-5. PMC: 193580. DOI: 10.1073/pnas.1832855100. View

20.

Kimura T, Jin J, Zi M, Prehar S, Liu W, Oceandy D . Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart. Circ Res. 2010; 106(5):961-70. PMC: 3003662. DOI: 10.1161/CIRCRESAHA.109.209320. View